Mouse Study Suggests Xenon Gas May Treat Alzheimer's Disease, Reduces Inflammation
Jan 15, 2025, 07:42 PM
A recent mouse study has explored the potential use of xenon gas as a treatment for Alzheimer's disease. The research indicates that inhaling xenon may modulate brain microglia and reduce inflammation, presenting a novel approach to combating the disease. The authors of the study, published in the journal 'Science', describe this method as an 'out of the box approach' that could offer a 'ray of hope' if validated through clinical trials. Additionally, another study highlighted the benefits of aerobic exercise in reducing brain inflammaging, particularly in the hippocampus, suggesting that lifestyle interventions may also play a role in Alzheimer's management.
View original story
Markets
No • 50%
Yes • 50%
Clinical trial registries such as ClinicalTrials.gov
Yes • 50%
No • 50%
Scientific journals and publications
No • 50%
Yes • 50%
Clinical trial registries such as ClinicalTrials.gov
Published in 'Science' • 25%
Published in another major journal • 25%
Published in 'The Lancet' • 25%
Published in 'Nature' • 25%
Major scientific review articles or meta-analyses
Other non-pharmacological interventions • 25%
Xenon gas treatment • 25%
Aerobic exercise • 25%
Other pharmacological treatments • 25%
Scientific journals and publications comparing interventions
Neither • 25%
Both FDA and EMA • 25%
EMA • 25%
FDA • 25%
Regulatory announcements from entities like the FDA or EMA